Company intelligence / Profile preview

Canady Life Sciences

Takoma Park, Maryland, United States

Ownership: Private
Development stage: Other

Overview

FDA-cleared Canady Helios Cold Plasma Ablation System for soft tissue ablation during surgery, with Phase I data showing up to 80% non-local recurrence rate and 86% overall survival in advanced solid tumors.[2]

Therapeutic areas: Oncology
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Canady Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Canady Life Sciences.

Explore the full profile